Pioneering life scientists use biological sequencing machines like the C1 from Fluidigm to study cellular growth and pathology to better understand how diseases like cancer, lupus, diabetes and many others affect cell populations. The ability to look at individual cells, rather than making assumptions based on a whole population, is enabling unprecedented understanding of these diseases and how to treat them.
This infographic presents compelling data that supports the need for expanded single-cell study, in support of the launch of the C1 system.
COCOYAY 